Nelson S H, Steinsland O S
Anesthesiology. 1983 Aug;59(2):98-101. doi: 10.1097/00000542-198308000-00005.
d-Tubocurarine has been reported to inhibit the action of dopamine on mollusc neurons. The purpose of the present study was to determine whether or not d-tubocurarine acts as an antagonist on mammalian dopamine receptors. The isolated, perfused rabbit ear artery was the experimental preparation used. In this preparation dopamine and apomorphine produced concentration-dependent inhibition of the response to electrical field stimulation of the periarterial sympathetic nerves. d-Tubocurarine antagonized the inhibitory effect of dopamine and apomorphine in a competitive manner. The calculated dissociation constants for d-tubocurarine acting against dopamine and apomorphine were 1.9 +/- 0.6 microM and 1.7 +/- 0.5 microM, respectively. d-Tubocurarine (1-100 microM), by itself, did not affect the response of the artery to sympathetic nerve stimulation. Other nicotinic antagonists hexamethonium, pancuronium and mecamylamine did not affect the dopamine action. These results suggest that d-tubocurarine could attenuate the therapeutic benefit of dopamine if both of these drugs are administered concomitantly.
据报道,d - 筒箭毒碱可抑制多巴胺对软体动物神经元的作用。本研究的目的是确定d - 筒箭毒碱是否作为哺乳动物多巴胺受体的拮抗剂。所用的实验制剂是离体灌注兔耳动脉。在此制剂中,多巴胺和阿扑吗啡对动脉周围交感神经电场刺激的反应产生浓度依赖性抑制。d - 筒箭毒碱以竞争性方式拮抗多巴胺和阿扑吗啡的抑制作用。计算得出d - 筒箭毒碱对多巴胺和阿扑吗啡的解离常数分别为1.9±0.6微摩尔和1.7±0.5微摩尔。d - 筒箭毒碱(1 - 100微摩尔)单独使用时,不影响动脉对交感神经刺激的反应。其他烟碱拮抗剂六甲铵、泮库溴铵和美加明不影响多巴胺的作用。这些结果表明,如果同时给予这两种药物,d - 筒箭毒碱可能会减弱多巴胺的治疗效果。